GLP-1s don’t always work for weight loss. Researchers are trying to figure out whyGLP-1s don’t always work for weight loss. Researchers are trying to figure out why
GLP-1 weight loss drugs have transformed obesity treatment, but not everyone loses lots of weight. Researchers say figuring out why is the key to the future of this treatment method. GLP-1 weight loss drugs have transformed obesity treatment, but not everyone loses lots of weight. Researchers say figuring out why is the key to Read More
Opinion: STAT+: What Ozempic might tell us about the future of Alzheimer’sOpinion: STAT+: What Ozempic might tell us about the future of Alzheimer’s
In the weeks leading up to Dec. 3, I imagined a fantastic headline: “Ozempic treats Alzheimer’s disease.” On that day, at the CtAD 2025 meeting (CtAD stands for Clinical Trials in Alzheimer’s Disease), in the Sapphire Ballroom of the Hilton San Diego Bayfront hotel, Novo Nordisk would present to the assembly of scientists and biopharma Read More
Incretin-Based Therapies and Post–Bariatric Surgery Alcohol Use DisorderIncretin-Based Therapies and Post–Bariatric Surgery Alcohol Use Disorder
This cohort study evaluates whether incretin-based therapy after bariatric surgery is associated with a lower risk of new-onset alcohol use disorder and initiation of medications for alcohol use disorder compared with non–incretin-based therapy antiobesity medications.
Incretin-Based Therapies and Risk of Alcohol Use Disorder After Bariatric SurgeryIncretin-Based Therapies and Risk of Alcohol Use Disorder After Bariatric Surgery
Gastroenterology and Hepatology
Obesity expert reveals the best way to decide if GLP-1s are right for youObesity expert reveals the best way to decide if GLP-1s are right for you
Some experts believe that anyone could benefit from GLP-1 medications, as the popular drugs have become more widespread and accessible. Others, however, warn that the decision to take the diabetes and weight-loss drugs should be based on health history and potential risks. So, how do you know if you’re a good candidate? In an interview Read More
Ozempic is changing the foods Americans buyOzempic is changing the foods Americans buy
When Americans begin taking appetite-suppressing drugs like Ozempic and Wegovy, the changes extend well beyond the bathroom scale. According to new research, the medications are associated with meaningful reductions in how much households spend on food, both at the grocery store and at restaurants. When Americans begin taking appetite-suppressing drugs like Ozempic and Wegovy, the Read More
Study finds more comfortable option for guiding breast cancer surgeryStudy finds more comfortable option for guiding breast cancer surgery
A new study led by researchers at Wake Forest University School of Medicine and Atrium Health Levine Cancer has found that a modern technique for locating breast tumors before surgery, called radioactive seed localization (RSL), is just as effective as the traditional wire localization (WL) method, while offering patients and surgeons a better overall experience.
I’m a Doctor Who Tried GLP-1 Drugs. Here’s How They Changed My Life.I’m a Doctor Who Tried GLP-1 Drugs. Here’s How They Changed My Life.
(MedPage Today) — In this video, Mikhail Varshavski, DO, who goes by “Dr. Mike,” talks with Christle Guevarra, DO, MS, about her struggle with weight, her journey with GLP-1 drugs, and her career in medicine. Following is a partial transcript… (MedPage Today) — In this video, Mikhail Varshavski, DO, who goes by “Dr. Mike,” Read More
For Black women with breast cancer, ultra-processed foods may worsen health outcomesFor Black women with breast cancer, ultra-processed foods may worsen health outcomes
A study by Rutgers Cancer Institute researchers is the first to link ultra-processed foods to reduced survival in Black women with breast cancer.
Establishing Connection and Trust With Breast Cancer PatientsEstablishing Connection and Trust With Breast Cancer Patients
(MedPage Today) — In “Beyond Diagnosis: Breast Cancer,” Cleveland Clinic oncologist Tiffany Onger, MD, and host John Mangels discuss the dynamics of communicating effectively and empathetically with patients facing the challenges of this life…